全文获取类型
收费全文 | 3209篇 |
免费 | 175篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 67篇 |
儿科学 | 94篇 |
妇产科学 | 112篇 |
基础医学 | 595篇 |
口腔科学 | 72篇 |
临床医学 | 265篇 |
内科学 | 509篇 |
皮肤病学 | 67篇 |
神经病学 | 248篇 |
特种医学 | 209篇 |
外科学 | 362篇 |
综合类 | 20篇 |
一般理论 | 1篇 |
预防医学 | 184篇 |
眼科学 | 46篇 |
药学 | 255篇 |
中国医学 | 4篇 |
肿瘤学 | 284篇 |
出版年
2023年 | 18篇 |
2022年 | 19篇 |
2021年 | 57篇 |
2020年 | 39篇 |
2019年 | 37篇 |
2018年 | 57篇 |
2017年 | 35篇 |
2016年 | 56篇 |
2015年 | 55篇 |
2014年 | 75篇 |
2013年 | 108篇 |
2012年 | 156篇 |
2011年 | 155篇 |
2010年 | 99篇 |
2009年 | 102篇 |
2008年 | 166篇 |
2007年 | 155篇 |
2006年 | 131篇 |
2005年 | 122篇 |
2004年 | 127篇 |
2003年 | 141篇 |
2002年 | 120篇 |
2001年 | 95篇 |
2000年 | 75篇 |
1999年 | 98篇 |
1998年 | 42篇 |
1997年 | 34篇 |
1996年 | 24篇 |
1995年 | 31篇 |
1994年 | 24篇 |
1993年 | 22篇 |
1992年 | 78篇 |
1991年 | 43篇 |
1990年 | 52篇 |
1989年 | 51篇 |
1988年 | 29篇 |
1987年 | 33篇 |
1986年 | 32篇 |
1985年 | 45篇 |
1984年 | 29篇 |
1983年 | 20篇 |
1982年 | 23篇 |
1978年 | 25篇 |
1977年 | 21篇 |
1976年 | 21篇 |
1974年 | 20篇 |
1973年 | 18篇 |
1972年 | 31篇 |
1971年 | 27篇 |
1970年 | 18篇 |
排序方式: 共有3394条查询结果,搜索用时 15 毫秒
61.
62.
63.
Javier Arístegui Vytautas Usonis Hoosen Coovadia Stella Riedemann Khin Maung Win Salvacion Gatchalian Hans L Bock 《International journal of infectious diseases》2003,7(2):143-151
BACKGROUND: Vaccines are important weapons in the fight against infectious diseases. The World Health Organization (WHO) Expanded Program on Immunization (EPI) has been extended to include recommendations for hepatitis B and Haemophilus influenzae type b (Hib) vaccinations. The WHO has recommended that combined vaccines be used where possible, to reduce the logistic costs of vaccine delivery. This paper reviews the efficacy, safety and cost-effectiveness of Tritanrix-HB/Hib, the only commercially available combined diphtheria, tetanus, whole cell pertussis, hepatitis B and conjugated Hib vaccine. METHODS: The immunogenicity and reactogenicity results of five published clinical trials involving Tritanrix-HB/Hib in a variety of immunization schedules and countries were reviewed. Based on these data and cost-effectiveness studies, an assessment of its suitability for use in national immunization programs was made. RESULTS: Tritanrix-HB/Hib has shown excellent immunogenicity in clinical trials using a variety of schedules, with no reduced immunogenicity observed for any of the components of the combined vaccine. It has similar reactogenicity to DTPw vaccines alone. Pharmacoeconomic analyses have shown combined DTP-HB/Hib vaccines to be cost-effective compared to separate vaccines. CONCLUSIONS: Replacement of DTPw vaccination by Tritanrix-HB/Hib can be done without modifying the existing national immunization programs. This should facilitate widespread coverage of hepatitis B and Hib vaccinations and their rapid incorporation into the EPI. 相似文献
64.
Hu L Lytras A Bock ME Yuen CK Dodd JG Cattini PA 《Molecular and cellular endocrinology》1999,157(1-2):131-142
Diabetes is a common complication encountered during pregnancy. Earlier studies indicated that diabetic placentas bear morphological alterations consistent with modified placental differentiation, including alterations in the villous cellular content, structure, and total surface. Limited data associating the diabetic status with the expression of terminal placental differentiation markers are available. The human growth hormone/chorionic somatomammotropin (hGH/CS) family consists of five genes, one of which (GH-N) is expressed efficiently in pituitary while the other four (CS-A, B, L, and hGH-V) are expressed in placenta and represent ultimate placental differentiation markers. We developed and applied a sensitive RT-PCR method coupled with diagnostic restriction digestion to determine the relative levels of the hGH/CS family in normal pregnancies and examine whether their mRNA expression pattern is altered in pregnancies complicated by diabetes. We show that relative hCS-L content changes during placental development. Specifically, normal term placentas express higher relative levels of hCS-L, lower relative hGH-V levels and a 70-fold lower hGH-V/CS-L mRNA ratio compared to early placentas. Also, many term placentas from diabetic pregnancies express lower relative levels of hCS-L mRNA and a much higher hGH-V/CS-L mRNA ratio compared to normal term placenta, resembling more an early placenta pattern of expression. Thus, our study suggests that the expression of terminal placental differentiation markers, such as the hGH/CS genes, is altered in term placentas from these diabetics reflecting either impaired placental differentiation or post-differentiation impairment of normal placental function. 相似文献
65.
66.
67.
Scheding S Meister B Bühring HJ Baum CM Mc Kearn JP Bock T Kanz L Brugger W 《Experimental hematology》2000,28(4):460-470
OBJECTIVE: Neutropenia following high-dose chemotherapy and peripheral blood progenitor cell (PBPC) transplantation might be abrogated by an additional transplantation of ex vivo generated granulopoietic postprogenitor cells (GPPC). Therefore, the ex vivo expansion of CD34(+) PBPC was systematically studied aiming for optimum GPPC production. MATERIALS AND METHODS: CD34(+) PBPC were cultured in serum-free medium comparing different (n = 32) combinations of stem cell factor (S), interleukin 1 (1), interleukin 3 (IL-3) (3), interleukin-6 (6), erythropoietin (E), granulocyte colony-stimulating factor (G), granulate-macrophage colony-stimulating factor (GM), daniplestim (D, a novel IL-3 receptor agonist), and Flt3 ligand (FL) under various culture conditions. Ex vivo generated cells were assessed by flow cytometry, morphology, and progenitor cell assays. RESULTS: Addition of G +/- GM but not GM alone to cultures stimulated with S163E effectively induced the generation of GPPC. GPPC production was maximum after 12 to 14 days. Best expansion rates were observed when cells were cultured at 1.5x10(4)/mL in 21% O(2). Modifications of culture conditions were either less or equally effective (i.e., modification of starting cell concentrations, low oxygen, addition of serum albumin or autologous plasma, repetitive feeding). Comparison of different cytokine combinations revealed that the optimum GPPC expansion cocktail consisted of S6GD+FL (day 12: 130-fold cellular expansion, 32% myeloblasts/promyelocytes, 49.4% myelocytes/metamyelocytes, 12.4% bands/segmented), which furthermore expanded CD34(+) cells (3.4-fold) and clonogenic progenitors (13.4-fold). CONCLUSION: Using the S6DG+FL expansion cocktail, GPPC could be effectively produced ex vivo starting from positively selected CD34 PBPC, possibly enabling amelioration or even abrogation of posttransplant neutropenia. 相似文献
68.
Bodil Gessler David Bock Hans-Christian Pommergaard Jakob Burcharth Jacob Rosenberg Eva Angenete 《International journal of colorectal disease》2016,31(4):895-902
Purpose
The aim of this was to assess potential risk factors for anastomotic dehiscence in colon cancer surgery in a national cohort.Methods
All patients, who had undergone a resection of a large bowel segment with an anastomosis between 2008 and 2011, were identified in the Swedish Colon Cancer Registry. Patient factors, socioeconomic factors, surgical factors, and medication and hospital data were combined to evaluate risk factors for anastomotic dehiscence.Results
The prevalence of anastomotic dehiscence was 4.3 % (497/11 565). Male sex, ASA classification III–IV, prescribed medications, bleeding more than 300 mL, and uncommon colorectal resections were associated with a higher risk of anastomotic dehiscence. Hospital stay was increased with 14.5 days, and 30-day mortality as well as long-term mortality was higher in the anastomotic dehiscence group.Conclusions
There are several factors that are possible to know preoperatively or during surgery that can indicate whether an anastomosis is an appropriate option. Anastomotic dehiscence increases hospital stay and long-term mortality.69.
Low grade gastric mucosa associated lymphoid tissue lymphoma:Treatment strategies based on 10 year follow-up 总被引:2,自引:0,他引:2
Lee SK Lee YC Chung JB Chon CY Moon YM Kang JK Park IS Suh CO Yang WI 《World journal of gastroenterology : WJG》2004,10(2):223-226
AIM: To deduce strategic guidelines of gastric mucosa associated lymphoid tissue lymphoma (MALTOMA) by evaluating the long-term outcome of patients in respect to various treatment modalities. METHODS: A total of 55 patients with MALTOMA from May 1992 to August 2002 were retrospectively reviewed. RESULTS: Complete remission was obtained in 24 (82.8%) of 29 patients treated with anti Helicobacter pylori (H pylori) regimen only. The duration to reach complete remission was 12 months (85 percentile, 2-33 months). Five patients showed complete remission with radiation therapy (26-86 months). Two of them were H pylori treatment failure cases. CONCLUSION: H pylori eradication is an effective primary treatment option for low grade MALTOMA and radiation therapy could be considered in patients with no evidence of H pylori infection or who do not respond to H pylori eradication therapy 12 months after successful eradication. 相似文献
70.
T Weinke T Loscher K Fleischer H Kretschmer H D Pohle B Kohler T Schlunk R Clemens H L Bock 《The American journal of tropical medicine and hygiene》1992,47(1):1-5
A multicenter prospective trial was performed to investigate the efficacy and the tolerability of halofantrine in nonimmune patients with malaria imported from areas with drug-resistant falciparum parasites (mainly Africa). Forty-five of the 74 subjects were treated with a one-day regimen (3 x 500 mg) of halofantrine, and the other 29 received the same regimen with an additional treatment on day 7. In the second group, a 100% efficacy rate was demonstrated, but in the group receiving the one-day regimen, four recrudescences were observed in patients with falciparum malaria. Only five mild adverse reactions were seen, which disappeared spontaneously after the end of the treatment. We conclude that halofantrine is highly effective in curing malaria in nonimmune subjects. The treatment scheme for such persons should include an additional treatment on day 7 for nonimmune individuals. This drug was well tolerated in our patients, indicating that halofantrine will be useful in the treatment of multidrug-resistant malaria in nonimmune persons. 相似文献